Roche-Hansoh, Merck KGaA-Silence, and Lilly-METiS deals show how ADCs, siRNA, and lipid nanoparticles reshape demands on CMC and manufacturing teams.
This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.